BC Drug and Poison Information Centre - Poison Control Service 1.800.567.8911           

Dr. Danuta Skowronski

Physician Epidemiologist, BCCDC and Clinical Professor, School of Population & Public Health, UBC
     Click photo to enlarge

Dr. Danuta Skowronski has been Epidemiology Lead for Influenza and Emerging Respiratory Pathogens at the BC Centre for Disease Control (BCCDC) for approximately 15 years. In this post, she is responsible for surveillance and rapid response research, a role for which she has been distinguished for her notable contributions around several major public health events.

Dr. Skowronski led the public health response to SARS in BC in 2003, and was responsible for human health recommendations during outbreaks of avian influenza in BC in 2004. In addition to being a member of Canada's National Advisory Committee on Immunization from 2008 - 2011, Dr. Skowronski has been involved in numerous provincial- and national-level pandemic planning activities and committees since 1998. Dr. Skowronski has more than 100 publications, primarily related to influenza, and has been recognized for her distinguished career in public health.   

In 2001, Dr. Skowronski received the Award for Excellence in Public Health from the Provincial Health Officer of BC. The BC Pharmacy Association also acknowledged her with the Award of Excellence in 2003 for her contribution to quality of life in BC and she was named Woman of Distinction in delivering the 15th Hycroft Lecture for the University of BC’s Women’s Club of Vancouver. In 2007, Dr. Skowronski was recipient of the University of BC President’s Award for Public Education through Media and in 2010, the Vancouver SUN similarly recognized Dr. Skowronski, naming her among the 100 most influential women of BC. In 2011, Dr. Skowronski was awarded the James M. Robinson Award by the University of British Columbia, Faculty of Medicine for her significant contributions to public health.   

Dr. Skowronski completed her medical degree and family medicine training at Queen’s University in Kingston, Ontario and completed a Master’s of Health Sciences degree and a Fellowship in Community Medicine at the University of British Columbia. She is further certified with the American Board of Preventive Medicine and completed additional training with the London School of Hygiene and Tropical Medicine. She worked for several years as an associate Medical Health Officer in Surrey, BC gaining practical experience in public health before joining the BCCDC in 1998 to pursue her interests in surveillance, applied public health research and policy development. 

Select publications: 

Skowronski DM, Chambers C, Sabaiduc S, et al. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. J Infect Dis 2015. pii:jiv177 [Epub ahead of print]

Skowronski DM, Chambers C, Sabaiduc S, et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. Euro Surveill 2015;20(4). pii: 21022.

Skowronski DM, Chambers C, Sabaiduc S, et al. Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada. J Infect Dis 2015;211(1):109-14. doi: 10.1093/infdis/jiu366.

Skowronski DM, Janjua NZ, De Serres G, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain, not antigenic drift in circulating viruses. PLoS One 2014;9:e92153. Doi: 10.1371/journal.pone.0092153. eCollection 2014  

Skowronski DM, Hamelin ME, De Serres G, et al. Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk. PLoS One. 2014;9:e86555. Doi: 10.1371/journal.pone.0086555. eCollection 2014.  

Defay F, De Serres G, Skowronski DM, et al. Measles in children vaccinated with 2 doses of MMR. Pediatrics 2013;132:e1126-33. Doi: 10.1542/peds.2012-3975.  

Skowronski DM, Janjua NZ, Tsafack EP, et al. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012 2012;54:318-27.  

Skowronski DM, Janjua NZ, De Serres G, et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis 2012;206:1852-61.  

Skowronski DM, Hottes TS, Chong M, et al. Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics 2011;128:e276-89.  

Skowronski DM, De Serres G, Crowcroft NS, et al and the Canadian SAVOIR Team. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med. 2010 6;7(4):e1000258.    

De Serres G, Skowronski DM, Mimault P, et al. Bats in the bedroom, bats in the belfry: reanalysis of the rationale for rabies post-exposure prophylaxis. Clin Infect Dis 2009;48:1493-9.

For full list of publications and citations in Google Scholar click here.

For publications in PubMed click here.
Last Updated: June 16, 2015